18 March 2021
Bird & Bird advises Elixinol on the acquisition of CannaCare
www.twobirds.com/en/news/press-releases/2021/global/bird-advises-elixinol-on-the-acquisition-of-cannacare

Bird & Bird has advised publicly traded Australian Elixinol Global Limited on the acquisition of leading German CBD company, CannaCare Health GmbH, Hamburg, by a Dutch subsidiary.

24 April 2020
Bird & Bird team shortlisted in multiple categories for the 8th annual LMG Life Sciences Awards 2020 Europe
www.twobirds.com/en/news/press-releases/2020/global/bird-and-bird-team-shortlisted-in-multiple-categories-for-the-8th-annual-lmg-life-sciences-awards

Our international Life Sciences & Healthcare Group is extremely proud to have been recognised among individuals and companies behind the most innovative and challenging Life Sciences work of the past year, as well as ...

26 January 2021
Bird & Bird advises MSA Safety on the acquisition of U.K. firefighter turnout gear manufacturer Bristol Uniforms
www.twobirds.com/en/news/press-releases/2021/uk/bird-bird-advises-msa-safety-on-the-acquisition-of-uk-firefighter-turnout-gear-manufacturer

International law firm Bird & Bird advised global safety equipment manufacturer MSA Safety Incorporated (NYSE: MSA) on the acquisition of U.K.-based Bristol Uniforms (“Bristol”) in an all-cash transaction valued at ...

22 July 2020
Bird & Bird advises InGeneron on divestment of Eticur GmbH
www.twobirds.com/en/news/press-releases/2020/global/bird-and-bird-advises-ingeneron-on-divestment-of-eticur-gmbh

Bird & Bird LLP has advised the US company InGeneron on the sale of 100% of the shares in the Munich-based private umbilical cord blood banking company Eticur GmbH to Polski Bank Komórek Macierzystych.

01 June 2020
Bird & Bird law firm advised Indian vaccine manufacturer Serum Institute of India Pvt. Ltd (part of Cyrus Poonawalla Group) on the sale of Czech unit, Praha Vaccines a.s., to Novavax AB
www.twobirds.com/en/news/press-releases/2020/czech-republic/bird-and-bird-law-firm-advised-indian-vaccine-manufacturer-serum-institute-of-india-pvt-ltd

Bird & Bird law firm advised Indian vaccine manufacturer Serum Institute of India Pvt. Ltd (part of Cyrus Poonawalla Group) on the sale of Czech unit, Praha Vaccines a.s., to Novavax AB, subsidiary of Novavax Inc, US ...

12 October 2020
Bird & Bird advises AddLife on the acquisition of Ropox A/S
www.twobirds.com/en/news/articles/2020/denmark/addlife---corporate

The Swedish listed company AddLife AB is a market leading player within Life Science offering quality products and advice to both the private and the public sectors, primarily in the Nordics and the rest of Europe.

29 October 2018
Bird & Bird grows its Corporate group with the appointment of James Baillieu as partner in London
www.twobirds.com/en/news/press-releases/2018/global/bird-bird-grows-its-corporate-group-with-the-appointment-of-james-baillieu-as-partner-in-london

International law firm Bird & Bird today expands its Corporate practice group with the appointment of James Baillieu as a partner in London.

10 August 2020
Bird & Bird LLP's Equity Capital Markets team successfully close numerous deals in Q2 2020
www.twobirds.com/en/news/press-releases/2020/global/bird-and-bird-llps-equity-capital-markets-team-successfully-close-numerous-deals-in-q2-2020

Our Equity Capital Markets Team has completed a number of deals this Quarter, across a wide variety of sectors.

12 April 2021
Bird & Bird's Spring PLC Update
www.twobirds.com/en/news/articles/2021/uk/bird-and-birds-spring-plc-update

We are pleased to issue the latest edition of Bird & Bird's PLC Update, a periodical publication containing recent developments in the Equity Capital Markets arena. We hope that you enjoy reading our PLC Update. Please ...

14 July 2020
The EU Court of Justice provides guidance for the antitrust assessment of "pay-for-delay" agreements in the pharmaceutical sector.
www.twobirds.com/en/news/articles/2020/global/the-eu-court-of-justice-provides-guidance-for-the-antitrust

The Court of Justice provided guidance for the antitrust assessment of agreements between competitors in the pharmaceutical sector. The Court's judgment is relevant because it addresses fundamental issues that have been ...